AI-generated summary
The authors compared 0.3% apitoxin (bee venom) gel with diode laser photobiomodulation in 60 people with recurrent aphthous ulcers, measuring pain, ulcer size and depth over five days. Both groups improved, and the authors report that the apitoxin group had greater improvement in pain and ulcer depth, with no significant difference in ulcer surface area. The study was a single comparison of two treatments, and the authors note their conclusions are limited to this trial setting.
- Participants
- 60
- Who or what was studied
- Adults with symptomatic recurrent aphthous ulcers measuring at least 4 mm
- Limits stated in the abstract
- The abstract does not describe limits beyond a single two-group comparison over five days, so follow-up duration and long-term outcomes are unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Visual analogue scale, Photobiomodulation therapy, Trial registration, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.